InvestorsHub Logo
Followers 8
Posts 2087
Boards Moderated 0
Alias Born 07/31/2006

Re: Rawnoc post# 97215

Thursday, 08/21/2014 8:25:38 AM

Thursday, August 21, 2014 8:25:38 AM

Post# of 146235
NONSENSE! The way in which NanoViricides has farmed out their pre-clinical research has been masterful! It has somewhat increased the time required to conduct some of the studies, but it's TREMENDOUSLY REDUCED THE COST of those studies for the company and the shareholders!

This once Pink Sheet company has in nine years progressed through the BB all the way to become an NYSE affiliated company, NOW WITH NO DEBT, $40M IN THE BANK, AND ABOUT TO BEGIN THEIR TOX STUDY LEADING TO HUMAN CLINICAL TRIALS AND DRUG APPROVAL!

Had NNVC been required to themselves PAY for all the pre-clinical testing, the costs would have very significantly diluted shareholder value.

Their strategy has been MASTERFUL! How many companies make it from the Pink Sheets all the way to an NYSE affiliated exchange? Virtually none. Virtually none.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NNVC News